Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10301384 Antibodies to IL-15

Patent 10301384 was granted and assigned to Calypso Biotech SA on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12104178 DHFR tunable protein regulation
0
Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11965008 IL-2 muteins and uses thereof
0
Edits on 4 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11945852 IL-2 muteins and uses thereof
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+456 characters)
Article

Patent abstract

The present invention relates to antibodies binding IL-15, in particular humanized antibodies. In particular, the anti-IL-15 antibodies according to the invention are able to neutralize IL-15 activity and are useful in the prevention and/or treatment of an autoimmune disease and/or inflammatory disorder, a malignancy, transplant rejection, metabolic condition and/or an infectious disease caused by parasitic, viral or bacterial pathogens.

Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11779632 IL-2 muteins and uses thereof
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1030138400
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 10961310 Targeted immunotolerance
0
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 10676516 Targeted immunotolerance
0
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Calypso Biotech SA
Calypso Biotech SA
0
Current Assignee
Calypso Biotech SA
Calypso Biotech SA
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103013840
Date of Patent
May 28, 2019
0
Patent Application Number
153207630
Date Filed
July 1, 2015
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103013840
Patent Citations Received
‌
US Patent 10676516 Targeted immunotolerance
0
‌
US Patent 10946068 IL-2 muteins and uses thereof
0
‌
US Patent 10961310 Targeted immunotolerance
0
‌
US Patent 11466068 Targeted immunotolerance
0
Patent Primary Examiner
‌
Prema M Mertz
0
Edits on 12 Oct, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11466068 Targeted immunotolerance
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Calypso Biotech SA
Calypso Biotech SA
0
Current Assignee
Calypso Biotech SA
Calypso Biotech SA
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103013840
Date of Patent
May 28, 2019
0
Patent Application Number
153207630
Date Filed
July 1, 2015
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103013840
Patent Citations Received
‌
US Patent 10676516 Targeted immunotolerance
0
‌
US Patent 10946068 IL-2 muteins and uses thereof
0
‌
US Patent 10961310 Targeted immunotolerance
0
Patent Primary Examiner
‌
Prema M Mertz
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 10961310 Targeted immunotolerance
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10301384
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10961310 Targeted immunotolerance
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10946068 IL-2 muteins and uses thereof
Edits on 4 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10676516 Targeted immunotolerance
Edits on 26 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10301384 Antibodies to IL-15

Infobox
Is a
Patent
Patent
Patent applicant
Calypso Biotech SA
Calypso Biotech SA
Current assignee
Calypso Biotech SA
Calypso Biotech SA
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10301384
Date of patent
May 28, 2019
Patent application number
15320763
Date Filed
July 1, 2015
Patent primary examiner
‌
Prema M Mertz

Find more entities like US Patent 10301384 Antibodies to IL-15

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo